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Background: Anemia is common in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary 
intervention (PCI), and portends a poor prognosis. Whether the prognostic impact of anemia in STEMI varies according to gender is unknown.
Methods: In the HORIZONS-AMI trial, patients were randomized to bivalirudin alone vs. unfractionated heparin (UFH) plus a glycoprotein IIb/IIIa 
inhibitor (GPI).
Results: Baseline anemia (defined as a hematocrit value at initial presentation <39% for men and <36% for women) was present in 331 of 3,153 
patients (10.5%), including 9.7% of men and 13.2% of women (P=0.008). Patients with vs. without baseline anemia had more than a 2-fold increase 
in major bleeding at 30 days (13.5% vs. 6.7%, P<0.0001) and at 1-year (14.8% vs. 7.2%, P<0.0001), an association which by multivariable analysis 
was independent of gender. Mortality was significantly higher in men with vs. without baseline anemia (4.6% vs. 1.8% at 30 days, P=0.003 and 8.9% 
vs. 3.0% at 1-year, P<0.0001) but not in women (5.3% vs. 3.6%, P=0.42 and 7.5% vs. 5.9%, P=0.54, respectively). By multivariable analysis, anemia 
independently predicted 1-year all-cause mortality in men but not in women.
Conclusions: Baseline anemia is associated with increased major bleeding and mortality in patients with STEMI undergoing primary PCI, but is a 
stronger predictor of early and late mortality in men than in women.
